Schedule 13G ownership disclosure

Biohaven Pharmaceutical Holding Co Ltd.

Security class unavailable

Event date: 2017-05-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,976,818
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-17-002348
Form type
SC 13G
Filer
Biohaven Pharmaceutical Holding Co Ltd.
CIK
CIK 1689813
Filed
May 12, 2017
Reporting period
May 09, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub